NorwayNorway

New staff

21.02.2009

Kalundborg – In January, Norwegian pharmaceutical company Pronova Bio-pharma ASA began recruiting employees for its new Danish plant, which is slated to go into operation within a year.
In 2007, Pronova invested a200m in the port town Kalundborg to double its production volume to 2,400 tons. The new facilities will be used to produce the company’s first commercialised omega-3-derived product – Omacor, a dietary adjunct for the treatment of elevated triglycerides produced from fish oil.

NorwayNorway

08.03.2012

With a bold approach, including next-generation DNA sequencing (NGS) and state-of-the-art biobanking systems, Norway is pushing forward personalised cancer treatments in its national health care system. Clinical-quality genome...

NorwayNorway

06.03.2012

Bionor Pharma ASA’s development of an HIV vaccine is back on track. In mid-February, the Oslo-based company announced positive results from a Phase IIb study. When combined with antiretroviral treatment, the Vacc-4x vaccine...

NorwayNorway

19.01.2012

Oslo – The north lights up with financial flares. Norwegian cancer specialist Clavis Pharma ASA has raised €21m through a placement of new shares. The 2.8 million shares represent approximately 9.4% of the current stock in the...

NorwayNorway

11.01.2012

Bergen – BerGenBio A/S announced it has completed an €6.9m Series A financing round. The money will be spent in taking their lead compound BGB324 into clinical trials and to develop a companion diagnostic. The lead investors are...

NorwayNorway

13.12.2011

Reykjavik – Iceland’s deCODE Genetics, which Arch Venture Partners and Polaris Venture Partners lifted out of bankruptcy in January 2010, has been making a comeback of late. In mid-October, the genome analyser announced it had...

NorwayNorway

01.10.2011

Oslo/Leverkusen – Norwegian radiotherapy specialist Algeta ASA and German drugmaker Bayer have presented new data on their cancer drug alpharadin. The radium-223-chloride pharmaceutical showed an increased overall survival rate...

NorwayNorway

30.09.2011

Lysaker/Osaka - Pronova Biopharma SA is set on entering the Japanese market with its TAK-085 (omega-3-acid ethyl esters 90) for the treatment of hyperlipidemia. Pronova's partner Takeda Pharmaceutical Company Limited submitted a...

NorwayNorway

14.06.2011

Laskut/Berlin – Researchers from Finland’s Technical Research Center VTT and the Charité Hospital in the German capital have come a step closer to a personalised diagnostic test for cancer. Matej Orešic (VTT) and Carsten Denkert...

NorwayNorway

12.06.2011

Oslo – Norwegian cancer drug development company Clavis Pharma ASA will receive a grant from the Norwegian government for the development of a companion diagnostic in acute myeloid leuk­aemia (AML). The Research Council of Norway...

NorwayNorway

17.05.2011

Oslo – Clavis Pharma ASA has signed a licensing deal with US firm Translational Therapeutics, Inc., for the development and commercialization of CP-4033, a patented Lipid Vector Technology (LVT) derivative of ribavirin under...

Displaying results 1 to 10 out of 92

1-10 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-norway/article/new-staff.html

Whitepaper

Product of the week

Products

Events

All Events

Stock list

All quotes

TOP

  • EVOCUTIS (UK)0.22 GBP15.79%
  • ADOCIA (F)68.80 EUR9.21%
  • WILEX (D)3.90 EUR8.94%

FLOP

  • SANTHERA (CH)89.00 CHF-5.82%
  • OXFORD BIOMEDICA (UK)9.15 GBP-5.67%
  • NEUROVIVE PHARMACEUTICAL AB (S)21.90 SEK-5.19%

TOP

  • PROTHENA PLC (IE)51.28 USD30.0%
  • DBV Technologies (F)52.65 EUR22.4%
  • BIOINVENT INTERNATIONAL AB (S)2.61 SEK17.0%

FLOP

  • NEUROVIVE PHARMACEUTICAL AB (S)21.90 SEK-54.2%
  • CHRONTECH PHARMA (S)0.01 SEK-50.0%
  • CELLECTIS (F)31.83 EUR-22.2%

TOP

  • ADOCIA (F)68.80 EUR386.2%
  • WILEX (D)3.90 EUR358.8%
  • 4SC (D)4.39 EUR352.6%

FLOP

  • CHRONTECH PHARMA (S)0.01 SEK-88.9%
  • ACTIVE BIOTECH (S)9.00 SEK-69.6%
  • NEOVACS (F)1.19 EUR-67.5%

No liability assumed, Date: 29.06.2015

Current issue

All issues